Company Filing History:
2 out of 869 
1 out of 318 
Years Active: 2016-2019
Title: Cécile Goujard: Innovator in HIV Research
Introduction
Cécile Goujard is a prominent inventor based in Paris, France. He has made significant contributions to the field of HIV research, particularly in identifying biomarkers for disease progression. His work has the potential to improve the lives of many individuals living with HIV.
Latest Patents
Cécile Goujard holds 2 patents. His latest patents focus on the levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS. The inventions provide methods for identifying patients capable of controlling HIV progression, as well as identifying an antagonist form of IP-10 associated with HIV progression control. These methods aim to improve the immunological response of HIV patients.
Career Highlights
Throughout his career, Cécile Goujard has worked with esteemed organizations such as Institut Pasteur and Assistance Publique-Hôpitaux de Paris. His research has been pivotal in advancing our understanding of HIV and its implications for patient care.
Collaborations
Cécile has collaborated with notable colleagues, including Michaela Müller-Trutwin and Mickaël J Y Ploquin. These partnerships have further enriched his research and contributed to the scientific community's knowledge of HIV.
Conclusion
Cécile Goujard's innovative work in HIV research exemplifies the impact of scientific inquiry on public health. His patents and collaborations highlight the importance of continued research in combating HIV and improving patient outcomes.